aluates Reports

$ 0.0

Automative

Global Galantamine Hydrobromide Orally Disintegrating Tablets Market Research Report 2025

Published Date: January 2025

Report Code: QYRE-Auto-31N18763

BUY CHAPTERS

Global Galantamine Hydrobromide Orally Disintegrating Tablets Market Research Report 2025

Code: QYRE-Auto-31N18763

Report

January 2025

Pages:76

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd.

Tianjin Meihua Biopharmaceutical Technology Co., Ltd.

Hebei Aierhaitai Pharmaceutical Co., Ltd.

Hefei Heyuan Pharmaceutical Co., Ltd.

Galantamine Hydrobromide Orally Disintegrating Tablets Market Size

The global market for Galantamine Hydrobromide Orally Disintegrating Tablets was valued at US$ 11.1 million in the year 2024 and is projected to reach a revised size of US$ 16.5 million by 2031, growing at a CAGR of 4.1% during the forecast period.

Galantamine Hydrobromide Orally Disintegrating Tablets Market

Galantamine hydrobromide orally disintegrating tablets are a pharmaceutical preparation containing galantamine hydrobromide as an active ingredient, designed for the treatment of cognitive impairment diseases such as Alzheimer's disease. The drug inhibits the activity of acetylcholinesterase and increases the concentration of acetylcholine in the brain, thereby improving patients' cognitive function and daily living ability.

North American market for Galantamine Hydrobromide Orally Disintegrating Tablets is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Galantamine Hydrobromide Orally Disintegrating Tablets is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Galantamine Hydrobromide Orally Disintegrating Tablets include Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd., Tianjin Meihua Biopharmaceutical Technology Co., Ltd., Hebei Aierhaitai Pharmaceutical Co., Ltd., Hefei Heyuan Pharmaceutical Co., Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Galantamine Hydrobromide Orally Disintegrating Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Galantamine Hydrobromide Orally Disintegrating Tablets.

The Galantamine Hydrobromide Orally Disintegrating Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Galantamine Hydrobromide Orally Disintegrating Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Galantamine Hydrobromide Orally Disintegrating Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Galantamine Hydrobromide Orally Disintegrating Tablets Market Report

Report Metric	Details
Report Name	Galantamine Hydrobromide Orally Disintegrating Tablets Market
Accounted market size in year	US$ 11.1 million
Forecasted market size in 2031	US$ 16.5 million
CAGR	4.1%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	12mg (Calculated as C₁₇H₂₁NO₃) 4mg (Calculated as C₁₇H₂₁NO₃) 8mg (Calculated as C₁₇H₂₁NO₃)
Segment by Application	Hospital Clinic Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd., Tianjin Meihua Biopharmaceutical Technology Co., Ltd., Hebei Aierhaitai Pharmaceutical Co., Ltd., Hefei Heyuan Pharmaceutical Co., Ltd.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Galantamine Hydrobromide Orally Disintegrating Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Galantamine Hydrobromide Orally Disintegrating Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Galantamine Hydrobromide Orally Disintegrating Tablets Market growing?

Ans: The Galantamine Hydrobromide Orally Disintegrating Tablets Market witnessing a CAGR of 4.1% during the forecast period 2025-2031.

What is the Galantamine Hydrobromide Orally Disintegrating Tablets Market size in 2031?

Ans: The Galantamine Hydrobromide Orally Disintegrating Tablets Market size in 2031 will be US$ 16.5 million.

Who are the main players in the Galantamine Hydrobromide Orally Disintegrating Tablets Market report?

Ans: The main players in the Galantamine Hydrobromide Orally Disintegrating Tablets Market are Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd., Tianjin Meihua Biopharmaceutical Technology Co., Ltd., Hebei Aierhaitai Pharmaceutical Co., Ltd., Hefei Heyuan Pharmaceutical Co., Ltd.

What are the Application segmentation covered in the Galantamine Hydrobromide Orally Disintegrating Tablets Market report?

Ans: The Applications covered in the Galantamine Hydrobromide Orally Disintegrating Tablets Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Galantamine Hydrobromide Orally Disintegrating Tablets Market report?

Ans: The Types covered in the Galantamine Hydrobromide Orally Disintegrating Tablets Market report are 12mg (Calculated as C₁₇H₂₁NO₃), 4mg (Calculated as C₁₇H₂₁NO₃), 8mg (Calculated as C₁₇H₂₁NO₃)

Recommended Reports

Neurological Treatments

Oral Formulations

Pharmaceutical Ingredients

1 Galantamine Hydrobromide Orally Disintegrating Tablets Market Overview

1.1 Product Definition

1.2 Galantamine Hydrobromide Orally Disintegrating Tablets by Type

1.2.1 Global Galantamine Hydrobromide Orally Disintegrating Tablets Market Value Comparison by Type (2024 VS 2031)

1.2.2 12mg (Calculated as C₁₇H₂₁NO₃)

1.2.3 4mg (Calculated as C₁₇H₂₁NO₃)

1.2.4 8mg (Calculated as C₁₇H₂₁NO₃)

1.3 Galantamine Hydrobromide Orally Disintegrating Tablets by Application

1.3.1 Global Galantamine Hydrobromide Orally Disintegrating Tablets Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Global Galantamine Hydrobromide Orally Disintegrating Tablets Market Size Estimates and Forecasts

1.4.1 Global Galantamine Hydrobromide Orally Disintegrating Tablets Revenue 2020-2031

1.4.2 Global Galantamine Hydrobromide Orally Disintegrating Tablets Sales 2020-2031

1.4.3 Global Galantamine Hydrobromide Orally Disintegrating Tablets Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Galantamine Hydrobromide Orally Disintegrating Tablets Market Competition by Manufacturers

2.1 Global Galantamine Hydrobromide Orally Disintegrating Tablets Sales Market Share by Manufacturers (2020-2025)

2.2 Global Galantamine Hydrobromide Orally Disintegrating Tablets Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Galantamine Hydrobromide Orally Disintegrating Tablets Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Galantamine Hydrobromide Orally Disintegrating Tablets, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Galantamine Hydrobromide Orally Disintegrating Tablets, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Galantamine Hydrobromide Orally Disintegrating Tablets, Product Type & Application

2.7 Global Key Manufacturers of Galantamine Hydrobromide Orally Disintegrating Tablets, Date of Enter into This Industry

2.8 Global Galantamine Hydrobromide Orally Disintegrating Tablets Market Competitive Situation and Trends

2.8.1 Global Galantamine Hydrobromide Orally Disintegrating Tablets Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Galantamine Hydrobromide Orally Disintegrating Tablets Players Market Share by Revenue

2.8.3 Global Galantamine Hydrobromide Orally Disintegrating Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Galantamine Hydrobromide Orally Disintegrating Tablets Market Scenario by Region

3.1 Global Galantamine Hydrobromide Orally Disintegrating Tablets Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Galantamine Hydrobromide Orally Disintegrating Tablets Sales by Region: 2020-2031

3.2.1 Global Galantamine Hydrobromide Orally Disintegrating Tablets Sales by Region: 2020-2025

3.2.2 Global Galantamine Hydrobromide Orally Disintegrating Tablets Sales by Region: 2026-2031

3.3 Global Galantamine Hydrobromide Orally Disintegrating Tablets Revenue by Region: 2020-2031

3.3.1 Global Galantamine Hydrobromide Orally Disintegrating Tablets Revenue by Region: 2020-2025

3.3.2 Global Galantamine Hydrobromide Orally Disintegrating Tablets Revenue by Region: 2026-2031

3.4 North America Galantamine Hydrobromide Orally Disintegrating Tablets Market Facts & Figures by Country

3.4.1 North America Galantamine Hydrobromide Orally Disintegrating Tablets Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Galantamine Hydrobromide Orally Disintegrating Tablets Sales by Country (2020-2031)

3.4.3 North America Galantamine Hydrobromide Orally Disintegrating Tablets Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Galantamine Hydrobromide Orally Disintegrating Tablets Market Facts & Figures by Country

3.5.1 Europe Galantamine Hydrobromide Orally Disintegrating Tablets Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Galantamine Hydrobromide Orally Disintegrating Tablets Sales by Country (2020-2031)

3.5.3 Europe Galantamine Hydrobromide Orally Disintegrating Tablets Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Galantamine Hydrobromide Orally Disintegrating Tablets Market Facts & Figures by Region

3.6.1 Asia Pacific Galantamine Hydrobromide Orally Disintegrating Tablets Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Galantamine Hydrobromide Orally Disintegrating Tablets Sales by Region (2020-2031)

3.6.3 Asia Pacific Galantamine Hydrobromide Orally Disintegrating Tablets Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Galantamine Hydrobromide Orally Disintegrating Tablets Market Facts & Figures by Country

3.7.1 Latin America Galantamine Hydrobromide Orally Disintegrating Tablets Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Galantamine Hydrobromide Orally Disintegrating Tablets Sales by Country (2020-2031)

3.7.3 Latin America Galantamine Hydrobromide Orally Disintegrating Tablets Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Galantamine Hydrobromide Orally Disintegrating Tablets Market Facts & Figures by Country

3.8.1 Middle East and Africa Galantamine Hydrobromide Orally Disintegrating Tablets Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Galantamine Hydrobromide Orally Disintegrating Tablets Sales by Country (2020-2031)

3.8.3 Middle East and Africa Galantamine Hydrobromide Orally Disintegrating Tablets Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Galantamine Hydrobromide Orally Disintegrating Tablets Sales by Type (2020-2031)

4.1.1 Global Galantamine Hydrobromide Orally Disintegrating Tablets Sales by Type (2020-2025)

4.1.2 Global Galantamine Hydrobromide Orally Disintegrating Tablets Sales by Type (2026-2031)

4.1.3 Global Galantamine Hydrobromide Orally Disintegrating Tablets Sales Market Share by Type (2020-2031)

4.2 Global Galantamine Hydrobromide Orally Disintegrating Tablets Revenue by Type (2020-2031)

4.2.1 Global Galantamine Hydrobromide Orally Disintegrating Tablets Revenue by Type (2020-2025)

4.2.2 Global Galantamine Hydrobromide Orally Disintegrating Tablets Revenue by Type (2026-2031)

4.2.3 Global Galantamine Hydrobromide Orally Disintegrating Tablets Revenue Market Share by Type (2020-2031)

4.3 Global Galantamine Hydrobromide Orally Disintegrating Tablets Price by Type (2020-2031)

5 Segment by Application

5.1 Global Galantamine Hydrobromide Orally Disintegrating Tablets Sales by Application (2020-2031)

5.1.1 Global Galantamine Hydrobromide Orally Disintegrating Tablets Sales by Application (2020-2025)

5.1.2 Global Galantamine Hydrobromide Orally Disintegrating Tablets Sales by Application (2026-2031)

5.1.3 Global Galantamine Hydrobromide Orally Disintegrating Tablets Sales Market Share by Application (2020-2031)

5.2 Global Galantamine Hydrobromide Orally Disintegrating Tablets Revenue by Application (2020-2031)

5.2.1 Global Galantamine Hydrobromide Orally Disintegrating Tablets Revenue by Application (2020-2025)

5.2.2 Global Galantamine Hydrobromide Orally Disintegrating Tablets Revenue by Application (2026-2031)

5.2.3 Global Galantamine Hydrobromide Orally Disintegrating Tablets Revenue Market Share by Application (2020-2031)

5.3 Global Galantamine Hydrobromide Orally Disintegrating Tablets Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd.

6.1.1 Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd. Company Information

6.1.2 Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd. Description and Business Overview

6.1.3 Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd. Galantamine Hydrobromide Orally Disintegrating Tablets Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd. Galantamine Hydrobromide Orally Disintegrating Tablets Product Portfolio

6.1.5 Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd. Recent Developments/Updates

6.2 Tianjin Meihua Biopharmaceutical Technology Co., Ltd.

6.2.1 Tianjin Meihua Biopharmaceutical Technology Co., Ltd. Company Information

6.2.2 Tianjin Meihua Biopharmaceutical Technology Co., Ltd. Description and Business Overview

6.2.3 Tianjin Meihua Biopharmaceutical Technology Co., Ltd. Galantamine Hydrobromide Orally Disintegrating Tablets Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Tianjin Meihua Biopharmaceutical Technology Co., Ltd. Galantamine Hydrobromide Orally Disintegrating Tablets Product Portfolio

6.2.5 Tianjin Meihua Biopharmaceutical Technology Co., Ltd. Recent Developments/Updates

6.3 Hebei Aierhaitai Pharmaceutical Co., Ltd.

6.3.1 Hebei Aierhaitai Pharmaceutical Co., Ltd. Company Information

6.3.2 Hebei Aierhaitai Pharmaceutical Co., Ltd. Description and Business Overview

6.3.3 Hebei Aierhaitai Pharmaceutical Co., Ltd. Galantamine Hydrobromide Orally Disintegrating Tablets Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Hebei Aierhaitai Pharmaceutical Co., Ltd. Galantamine Hydrobromide Orally Disintegrating Tablets Product Portfolio

6.3.5 Hebei Aierhaitai Pharmaceutical Co., Ltd. Recent Developments/Updates

6.4 Hefei Heyuan Pharmaceutical Co., Ltd.

6.4.1 Hefei Heyuan Pharmaceutical Co., Ltd. Company Information

6.4.2 Hefei Heyuan Pharmaceutical Co., Ltd. Description and Business Overview

6.4.3 Hefei Heyuan Pharmaceutical Co., Ltd. Galantamine Hydrobromide Orally Disintegrating Tablets Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Hefei Heyuan Pharmaceutical Co., Ltd. Galantamine Hydrobromide Orally Disintegrating Tablets Product Portfolio

6.4.5 Hefei Heyuan Pharmaceutical Co., Ltd. Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Galantamine Hydrobromide Orally Disintegrating Tablets Industry Chain Analysis

7.2 Galantamine Hydrobromide Orally Disintegrating Tablets Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Galantamine Hydrobromide Orally Disintegrating Tablets Production Mode & Process Analysis

7.4 Galantamine Hydrobromide Orally Disintegrating Tablets Sales and Marketing

7.4.1 Galantamine Hydrobromide Orally Disintegrating Tablets Sales Channels

7.4.2 Galantamine Hydrobromide Orally Disintegrating Tablets Distributors

7.5 Galantamine Hydrobromide Orally Disintegrating Tablets Customer Analysis

8 Galantamine Hydrobromide Orally Disintegrating Tablets Market Dynamics

8.1 Galantamine Hydrobromide Orally Disintegrating Tablets Industry Trends

8.2 Galantamine Hydrobromide Orally Disintegrating Tablets Market Drivers

8.3 Galantamine Hydrobromide Orally Disintegrating Tablets Market Challenges

8.4 Galantamine Hydrobromide Orally Disintegrating Tablets Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd.

Tianjin Meihua Biopharmaceutical Technology Co., Ltd.

Hebei Aierhaitai Pharmaceutical Co., Ltd.

Hefei Heyuan Pharmaceutical Co., Ltd.

List of Tables

Table 1. Global Galantamine Hydrobromide Orally Disintegrating Tablets Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Galantamine Hydrobromide Orally Disintegrating Tablets Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Galantamine Hydrobromide Orally Disintegrating Tablets Market Competitive Situation by Manufacturers in 2024

Table 4. Global Galantamine Hydrobromide Orally Disintegrating Tablets Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Galantamine Hydrobromide Orally Disintegrating Tablets Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Galantamine Hydrobromide Orally Disintegrating Tablets Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Galantamine Hydrobromide Orally Disintegrating Tablets Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Galantamine Hydrobromide Orally Disintegrating Tablets Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Galantamine Hydrobromide Orally Disintegrating Tablets, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Galantamine Hydrobromide Orally Disintegrating Tablets, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Galantamine Hydrobromide Orally Disintegrating Tablets, Product Type & Application

Table 12. Global Key Manufacturers of Galantamine Hydrobromide Orally Disintegrating Tablets, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Galantamine Hydrobromide Orally Disintegrating Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Galantamine Hydrobromide Orally Disintegrating Tablets as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Galantamine Hydrobromide Orally Disintegrating Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Galantamine Hydrobromide Orally Disintegrating Tablets Sales by Region (2020-2025) & (K Units)

Table 18. Global Galantamine Hydrobromide Orally Disintegrating Tablets Sales Market Share by Region (2020-2025)

Table 19. Global Galantamine Hydrobromide Orally Disintegrating Tablets Sales by Region (2026-2031) & (K Units)

Table 20. Global Galantamine Hydrobromide Orally Disintegrating Tablets Sales Market Share by Region (2026-2031)

Table 21. Global Galantamine Hydrobromide Orally Disintegrating Tablets Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Galantamine Hydrobromide Orally Disintegrating Tablets Revenue Market Share by Region (2020-2025)

Table 23. Global Galantamine Hydrobromide Orally Disintegrating Tablets Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Galantamine Hydrobromide Orally Disintegrating Tablets Revenue Market Share by Region (2026-2031)

Table 25. North America Galantamine Hydrobromide Orally Disintegrating Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Galantamine Hydrobromide Orally Disintegrating Tablets Sales by Country (2020-2025) & (K Units)

Table 27. North America Galantamine Hydrobromide Orally Disintegrating Tablets Sales by Country (2026-2031) & (K Units)

Table 28. North America Galantamine Hydrobromide Orally Disintegrating Tablets Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Galantamine Hydrobromide Orally Disintegrating Tablets Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Galantamine Hydrobromide Orally Disintegrating Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Galantamine Hydrobromide Orally Disintegrating Tablets Sales by Country (2020-2025) & (K Units)

Table 32. Europe Galantamine Hydrobromide Orally Disintegrating Tablets Sales by Country (2026-2031) & (K Units)

Table 33. Europe Galantamine Hydrobromide Orally Disintegrating Tablets Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Galantamine Hydrobromide Orally Disintegrating Tablets Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Galantamine Hydrobromide Orally Disintegrating Tablets Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Galantamine Hydrobromide Orally Disintegrating Tablets Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Galantamine Hydrobromide Orally Disintegrating Tablets Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Galantamine Hydrobromide Orally Disintegrating Tablets Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Galantamine Hydrobromide Orally Disintegrating Tablets Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Galantamine Hydrobromide Orally Disintegrating Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Galantamine Hydrobromide Orally Disintegrating Tablets Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Galantamine Hydrobromide Orally Disintegrating Tablets Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Galantamine Hydrobromide Orally Disintegrating Tablets Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Galantamine Hydrobromide Orally Disintegrating Tablets Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Galantamine Hydrobromide Orally Disintegrating Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Galantamine Hydrobromide Orally Disintegrating Tablets Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Galantamine Hydrobromide Orally Disintegrating Tablets Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Galantamine Hydrobromide Orally Disintegrating Tablets Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Galantamine Hydrobromide Orally Disintegrating Tablets Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Galantamine Hydrobromide Orally Disintegrating Tablets Sales (K Units) by Type (2020-2025)

Table 51. Global Galantamine Hydrobromide Orally Disintegrating Tablets Sales (K Units) by Type (2026-2031)

Table 52. Global Galantamine Hydrobromide Orally Disintegrating Tablets Sales Market Share by Type (2020-2025)

Table 53. Global Galantamine Hydrobromide Orally Disintegrating Tablets Sales Market Share by Type (2026-2031)

Table 54. Global Galantamine Hydrobromide Orally Disintegrating Tablets Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Galantamine Hydrobromide Orally Disintegrating Tablets Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Galantamine Hydrobromide Orally Disintegrating Tablets Revenue Market Share by Type (2020-2025)

Table 57. Global Galantamine Hydrobromide Orally Disintegrating Tablets Revenue Market Share by Type (2026-2031)

Table 58. Global Galantamine Hydrobromide Orally Disintegrating Tablets Price (US$/Unit) by Type (2020-2025)

Table 59. Global Galantamine Hydrobromide Orally Disintegrating Tablets Price (US$/Unit) by Type (2026-2031)

Table 60. Global Galantamine Hydrobromide Orally Disintegrating Tablets Sales (K Units) by Application (2020-2025)

Table 61. Global Galantamine Hydrobromide Orally Disintegrating Tablets Sales (K Units) by Application (2026-2031)

Table 62. Global Galantamine Hydrobromide Orally Disintegrating Tablets Sales Market Share by Application (2020-2025)

Table 63. Global Galantamine Hydrobromide Orally Disintegrating Tablets Sales Market Share by Application (2026-2031)

Table 64. Global Galantamine Hydrobromide Orally Disintegrating Tablets Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Galantamine Hydrobromide Orally Disintegrating Tablets Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Galantamine Hydrobromide Orally Disintegrating Tablets Revenue Market Share by Application (2020-2025)

Table 67. Global Galantamine Hydrobromide Orally Disintegrating Tablets Revenue Market Share by Application (2026-2031)

Table 68. Global Galantamine Hydrobromide Orally Disintegrating Tablets Price (US$/Unit) by Application (2020-2025)

Table 69. Global Galantamine Hydrobromide Orally Disintegrating Tablets Price (US$/Unit) by Application (2026-2031)

Table 70. Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd. Company Information

Table 71. Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd. Description and Business Overview

Table 72. Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd. Galantamine Hydrobromide Orally Disintegrating Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd. Galantamine Hydrobromide Orally Disintegrating Tablets Product

Table 74. Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd. Recent Developments/Updates

Table 75. Tianjin Meihua Biopharmaceutical Technology Co., Ltd. Company Information

Table 76. Tianjin Meihua Biopharmaceutical Technology Co., Ltd. Description and Business Overview

Table 77. Tianjin Meihua Biopharmaceutical Technology Co., Ltd. Galantamine Hydrobromide Orally Disintegrating Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Tianjin Meihua Biopharmaceutical Technology Co., Ltd. Galantamine Hydrobromide Orally Disintegrating Tablets Product

Table 79. Tianjin Meihua Biopharmaceutical Technology Co., Ltd. Recent Developments/Updates

Table 80. Hebei Aierhaitai Pharmaceutical Co., Ltd. Company Information

Table 81. Hebei Aierhaitai Pharmaceutical Co., Ltd. Description and Business Overview

Table 82. Hebei Aierhaitai Pharmaceutical Co., Ltd. Galantamine Hydrobromide Orally Disintegrating Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Hebei Aierhaitai Pharmaceutical Co., Ltd. Galantamine Hydrobromide Orally Disintegrating Tablets Product

Table 84. Hebei Aierhaitai Pharmaceutical Co., Ltd. Recent Developments/Updates

Table 85. Hefei Heyuan Pharmaceutical Co., Ltd. Company Information

Table 86. Hefei Heyuan Pharmaceutical Co., Ltd. Description and Business Overview

Table 87. Hefei Heyuan Pharmaceutical Co., Ltd. Galantamine Hydrobromide Orally Disintegrating Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Hefei Heyuan Pharmaceutical Co., Ltd. Galantamine Hydrobromide Orally Disintegrating Tablets Product

Table 89. Hefei Heyuan Pharmaceutical Co., Ltd. Recent Developments/Updates

Table 90. Key Raw Materials Lists

Table 91. Raw Materials Key Suppliers Lists

Table 92. Galantamine Hydrobromide Orally Disintegrating Tablets Distributors List

Table 93. Galantamine Hydrobromide Orally Disintegrating Tablets Customers List

Table 94. Galantamine Hydrobromide Orally Disintegrating Tablets Market Trends

Table 95. Galantamine Hydrobromide Orally Disintegrating Tablets Market Drivers

Table 96. Galantamine Hydrobromide Orally Disintegrating Tablets Market Challenges

Table 97. Galantamine Hydrobromide Orally Disintegrating Tablets Market Restraints

Table 98. Research Programs/Design for This Report

Table 99. Key Data Information from Secondary Sources

Table 100. Key Data Information from Primary Sources

Table 101. Authors List of This Report

List of Figures

Figure 1. Product Picture of Galantamine Hydrobromide Orally Disintegrating Tablets

Figure 2. Global Galantamine Hydrobromide Orally Disintegrating Tablets Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Galantamine Hydrobromide Orally Disintegrating Tablets Market Share by Type: 2024 & 2031

Figure 4. 12mg (Calculated as C₁₇H₂₁NO₃) Product Picture

Figure 5. 4mg (Calculated as C₁₇H₂₁NO₃) Product Picture

Figure 6. 8mg (Calculated as C₁₇H₂₁NO₃) Product Picture

Figure 7. Global Galantamine Hydrobromide Orally Disintegrating Tablets Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Galantamine Hydrobromide Orally Disintegrating Tablets Market Share by Application: 2024 & 2031

Figure 9. Hospital

Figure 10. Clinic

Figure 11. Other

Figure 12. Global Galantamine Hydrobromide Orally Disintegrating Tablets Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Galantamine Hydrobromide Orally Disintegrating Tablets Market Size (2020-2031) & (US$ Million)

Figure 14. Global Galantamine Hydrobromide Orally Disintegrating Tablets Sales (2020-2031) & (K Units)

Figure 15. Global Galantamine Hydrobromide Orally Disintegrating Tablets Average Price (US$/Unit) & (2020-2031)

Figure 16. Galantamine Hydrobromide Orally Disintegrating Tablets Report Years Considered

Figure 17. Galantamine Hydrobromide Orally Disintegrating Tablets Sales Share by Manufacturers in 2024

Figure 18. Global Galantamine Hydrobromide Orally Disintegrating Tablets Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Galantamine Hydrobromide Orally Disintegrating Tablets Players: Market Share by Revenue in Galantamine Hydrobromide Orally Disintegrating Tablets in 2024

Figure 20. Galantamine Hydrobromide Orally Disintegrating Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Galantamine Hydrobromide Orally Disintegrating Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Galantamine Hydrobromide Orally Disintegrating Tablets Sales Market Share by Country (2020-2031)

Figure 23. North America Galantamine Hydrobromide Orally Disintegrating Tablets Revenue Market Share by Country (2020-2031)

Figure 24. United States Galantamine Hydrobromide Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Galantamine Hydrobromide Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Galantamine Hydrobromide Orally Disintegrating Tablets Sales Market Share by Country (2020-2031)

Figure 27. Europe Galantamine Hydrobromide Orally Disintegrating Tablets Revenue Market Share by Country (2020-2031)

Figure 28. Germany Galantamine Hydrobromide Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Galantamine Hydrobromide Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Galantamine Hydrobromide Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Galantamine Hydrobromide Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Galantamine Hydrobromide Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Galantamine Hydrobromide Orally Disintegrating Tablets Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Galantamine Hydrobromide Orally Disintegrating Tablets Revenue Market Share by Region (2020-2031)

Figure 35. China Galantamine Hydrobromide Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Galantamine Hydrobromide Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Galantamine Hydrobromide Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Galantamine Hydrobromide Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Galantamine Hydrobromide Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. China Taiwan Galantamine Hydrobromide Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Southeast Asia Galantamine Hydrobromide Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Latin America Galantamine Hydrobromide Orally Disintegrating Tablets Sales Market Share by Country (2020-2031)

Figure 43. Latin America Galantamine Hydrobromide Orally Disintegrating Tablets Revenue Market Share by Country (2020-2031)

Figure 44. Mexico Galantamine Hydrobromide Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Brazil Galantamine Hydrobromide Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Argentina Galantamine Hydrobromide Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Colombia Galantamine Hydrobromide Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Middle East and Africa Galantamine Hydrobromide Orally Disintegrating Tablets Sales Market Share by Country (2020-2031)

Figure 49. Middle East and Africa Galantamine Hydrobromide Orally Disintegrating Tablets Revenue Market Share by Country (2020-2031)

Figure 50. Turkey Galantamine Hydrobromide Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Galantamine Hydrobromide Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. UAE Galantamine Hydrobromide Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Global Sales Market Share of Galantamine Hydrobromide Orally Disintegrating Tablets by Type (2020-2031)

Figure 54. Global Revenue Market Share of Galantamine Hydrobromide Orally Disintegrating Tablets by Type (2020-2031)

Figure 55. Global Galantamine Hydrobromide Orally Disintegrating Tablets Price (US$/Unit) by Type (2020-2031)

Figure 56. Global Sales Market Share of Galantamine Hydrobromide Orally Disintegrating Tablets by Application (2020-2031)

Figure 57. Global Revenue Market Share of Galantamine Hydrobromide Orally Disintegrating Tablets by Application (2020-2031)

Figure 58. Global Galantamine Hydrobromide Orally Disintegrating Tablets Price (US$/Unit) by Application (2020-2031)

Figure 59. Galantamine Hydrobromide Orally Disintegrating Tablets Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Donepezil Hydrochloride Tablets Market Research Report 2024

Global Galantamine Hydrobromide API Market Research Report 2024

Global Cholinesterase Inhibitors for Alzheimer s Disease Market Research Report 2024

Global Medications for Alzheimer s Disease Market Research Report 2024

Global Olanzapine Orally Disintegrating Tablets Market Research Report 2024

Global Rivastigmine Tartrate Drug Market Research Report 2024

Memantine Hydrochloride Tablets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Orally Disintegrating Tablet Technology Market Research Report 2024

Global Galantamine Tablets Market Research Report 2024

Global Memantine Preparations Market Research Report 2024

Galantamine Hydrobromide Lycoremine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Memantine and Donepezil Hydrochlorides Compound Preparation Market Research Report 2024

Global Edoxaban Tosilate Orally Disintegrating Tablets Market Research Report 2024

Dementia Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Anti amyloid Drugs Market Research Report 2024

Global Donepezil Hydrochloride Market Research Report 2024

Global Rivastigmine Hydrogen Tartrate API Market Research Report 2024

Global Carglumic Acid Dispersible Tablets Market Research Report 2024

Global Freeze Dried Orally Disintegrating Tablets Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions